Effect of anti-tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis-A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic.
J Am Acad Dermatol
; 84(1): 161-163, 2021 01.
Article
em En
| MEDLINE
| ID: mdl-32860913
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Psoríase
/
Tomada de Decisão Clínica
/
Inibidores do Fator de Necrose Tumoral
/
COVID-19
/
Imunossupressores
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article